Antibodies are a stalwart tool in biomedical research. Most commonly used are animal-derived polyclonal and monoclonal antibodies (mAbs), and nonanimal-derived recombinant mAbs. According to Simon ...

Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...

MIAMI (CBSMiami) – As monoclonal antibody treatment centers open in South Florida and across the state, some people may be wondering exactly what is a monoclonal antibody? Monoclonal antibodies are ...

Monoclonal antibodies were approved as a COVID-19 treatment by the FDA last year, and again in February and May. This therapy works best for people who face severe complications from SARS-CoV-2—but it ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The FDA issued emergency use authorization for Eli Lilly’s monoclonal antibody, called ...

COVID-19 is once again surging throughout the U.S., but deaths from the disease don’t seem to be following suit. That’s partly because many people have some level of immunity from vaccination or ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

According to a statement from White House press secretary Kayleigh McEnany, Trump received an 8-gram dose of the polyclonal antibody cocktail, REGN-COV2, from pharmaceutical company Regeneron, as a ...

There are very few drugs that prevent people with early Covid-19 from progress to severe disease, but monoclonal antibodies may be among them. Early study results show they may reduce the rate of ...

The idea that antibodies could serve as therapeutics emerged over 100 years ago. Nevertheless, antibody therapeutics have taken a long time to come of age. At first, antibodies were poorly understood, ...

insights from industryDr. Thierry Le BihanPrincipal Scientist Rapid Novor Inc. In this interview, News-Medical spoke to Dr. Thierry Le Bihan, Principal Scientist for the REpAb™ project, about how ...